Selective gray matter damage in neuropsychiatric lupus.

Objective Damage of brain parenchyma in patients with primary diffuse neuropsychiatric systemic lupus erythematosus (NPSLE) has been indicated by magnetization transfer imaging (MTI). However, the location of MTI abnormalities is unknown. This study was undertaken to assess the distribution of MTI abnormalities over gray matter (GM) and white matter (WM) in SLE patients with a history of NP symptoms without explanatory magnetic resonance imaging (MRI) evidence of focal disease. Methods MTI was performed in 24 female SLE patients with a history of diffuse NP symptoms and 24 healthy female controls. Magnetization transfer ratio (MTR) maps were calculated for GM and WM separately, and GM and WM MTR histograms were generated. Univariate and multivariate analyses with age as an additional covariate were performed on the histogram parameters peak location (PL), peak height (PH), and mean MTR. Results Compared with controls, significantly reduced PH (mean ± SD 136 ± 22 arbitrary units versus 151 ± 13 arbitrary units) and mean MTR (33.3 ± 1.0 percent units versus 33.6 ± 0.5 percent units) were found in the GM of NPSLE patients (P = 0.002 and P = 0.033, respectively, in multivariate analyses). No significant differences were observed for WM MTR parameters. Conclusion This is the first study to demonstrate, using MTI, that in SLE patients with a history of NP symptoms and without explanatory focal abnormalities on MRI, the GM is particularly affected. These findings support the hypothesis that neuronal injury may underlie central nervous system manifestations in NPSLE.

[1]  R. Brey,et al.  Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). , 2002, Best practice & research. Clinical rheumatology.

[2]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[3]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[4]  M. van Buchem,et al.  Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging. , 2000, Arthritis and rheumatism.

[5]  W. Brooks,et al.  Neuroimaging in neuropsychiatric systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[6]  B. Diamond,et al.  A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus , 2001, Nature Medicine.

[7]  M. van Buchem,et al.  Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[8]  L. Rosengren,et al.  Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. , 2003, Arthritis and rheumatism.

[9]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[10]  M. van Buchem,et al.  Imaging modalities in central nervous system systemic lupus erythematosus , 2001, Current opinion in rheumatology.

[11]  P. V. van Zijl,et al.  Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. , 1997, The Journal of rheumatology.

[12]  Y. Iwasaki,et al.  Hypoxic brain damage: cortical laminar necrosis and delayed changes in white matter at sequential MR imaging. , 1993, Radiology.

[13]  R. Griffey,et al.  Spin-spin relaxation of brain tissues in systemic lupus erythematosus. A method for increasing the sensitivity of magnetic resonance imaging for neuropsychiatric lupus. , 1995, Arthritis and rheumatism.

[14]  N. Scolding,et al.  The neuropathology and pathogenesis of systemic lupus erythematosus , 2002, Neuropathology and applied neurobiology.

[15]  E. Richardson,et al.  The neurological manifestations of systemic lupus erythematosus. , 1968, Medicine.